PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Industry Recognition

31 Jan 2006 07:02

Sopheon PLC31 January 2006 Embargoed Release: 07:00hrs Tuesday 31st January 2006 Sopheon Plc ('Sopheon' or the 'Company') Leading IT Market Research Firm Cites Sopheon As First-Mover In Taking Advantage of Major Market Trend New Report Says Company Well-Positioned to Benefit From Convergence of Product Life Cycle and Portfolio Management Solutions Sopheon Plc, the international software and services company, announces todaythat global IT research and advisory firm IDC has published a profile analyzingSopheon and its flagship Accolade process and product portfolio managementsystem. The report credits Sopheon with early recognition of the convergence ofproduct life cycle management (PLM) and project portfolio management (PPM)solutions and taking effective action to capitalize on this trend, which IDCcharacterizes as a major, new market force. (Source: IDC, "Sopheon's AccoladeBreaking out in PLM and Portfolio Management Convergence," Doc #34274.) In an IDC Product Flash, analysts Evan Quinn and Gisela Wilson examine Sopheon'smarket position and the evolution of its flagship offering. From the analysts'perspective, Accolade's functional focus on improving the product developmentprocess, including recent enhancements to the solution, has separated it fromtraditional project portfolio management software and is positively impactingSopheon's business outlook. The report observes that Sopheon seems "particularly well positioned to ride thePLM/PPM convergence trend given its differentiated approach." Earmarks of thatapproach, according to IDC's analysis, include built-in support for the widelyused Stage-Gate(R) product development process framework; portals and analyticstargeted for process industries; integration with Microsoft(R) Project; andstrong portfolio management features. The commentary points to Sopheon'sexpanding sales pipeline, increasing deal size and its stepped-up pursuit ofindirect channel sales partnerships as validation that the company is movinginto a new phase of growth. "Sopheon stands out as a first mover in PLM/PPM convergence," the reportconcludes, "and possesses a position of leverage in Microsoft's businessapplication partnership community. Accolade is ahead of many of its moreestablished competitors in terms of how to leverage collaboration, portal, andcontent technologies for innovation management." "Generic project management tools can provide great value operationally," saidAndy Michuda, chief executive officer of Sopheon, "But they don't address theneeds of corporate executives for information that can help them make strategicproduct-development decisions. There's a growing body of evidence that one ofthe most important characteristics separating innovation leaders from the packis that they put in place a strong product innovation process and support itwith superior project management skills. Accolade enables organizations toquickly develop these capabilities as a sustainable competitive advantage. Oursolution was built from the ground up to manage projects within the businesscontext of the new product development process. And it has demonstrated that itcan produce break-through results. Being recognized as a "first-mover" in thisemerging market of applying project management best-practices to the productlife cycle management process is strong validation of our unique application andstrategic focus. Having this recognition come from one of the world's topindependent IT research and advisory firms is especially affirming." Sopheon Accolade(R) is a registered trademark of Sopheon plc. Stage-Gate(R) is a registered trademark of the Product Development Institute. Microsoft(R) is a registered trademark of Microsoft Corporation.All other trademarks and registered trademarks are the soleproperty of their respective owners. About Sopheon Sopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade(R) product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevant contentto healthcare and engineering professionals to enable effective compliance withprotocols, standards and regulations. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jul 20199:05 amRNSSecond Price Monitoring Extn
24th Jul 20199:00 amRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSTrading Update
13th Jun 20191:06 pmRNSResult of AGM
13th Jun 20197:00 amRNSAccolade 12.3
13th Jun 20197:00 amRNSAGM Statement
11th Jun 20191:32 pmRNSIssue of Equity
15th May 20197:00 amRNSSopheon Expands Customer Foothold in Asia
13th May 20199:14 amRNSIssue of Equity
28th Mar 20197:00 amRNSSopheon and National Foods Limited Partnership
21st Mar 20197:00 amRNSFinal Results
5th Feb 20197:00 amRNSIssue of Equity
29th Jan 20197:00 amRNSTrading Update
24th Jan 20194:41 pmRNSSecond Price Monitoring Extn
24th Jan 20194:35 pmRNSPrice Monitoring Extension
17th Jan 20197:00 amRNSAccolade Release 12.2
11th Jan 20197:00 amRNSTrading Update
8th Jan 20197:00 amRNSSopheon Partners with The Hershey Company
18th Dec 20182:53 pmRNSIssue of Equity
16th Nov 201812:54 pmRNSIssue of Equity
31st Oct 20185:18 pmRNSIssue of Equity
23rd Oct 20187:00 amRNSSopheon Awarded The Nature's Bounty Co. Business
8th Oct 20189:05 amRNSSecond Price Monitoring Extn
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSTrading Update
10th Sep 20187:00 amRNSDoosan Bobcat Awards Sopheon Innovation Contract
7th Sep 20185:48 pmRNSIssue of Equity
29th Aug 20183:54 pmRNSIssue of Equity & Holdings in Company
28th Aug 20187:00 amRNSAccolade Enterprise Innovation Management
23rd Aug 20187:00 amRNSHalf Yearly Report
19th Jul 201811:05 amRNSSecond Price Monitoring Extn
19th Jul 201811:00 amRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSTrading Update
5th Jul 20189:40 amRNSGrant of Options / PDMR Dealing
3rd Jul 20189:24 amRNSIssue of Equity
13th Jun 20182:37 pmRNSIssue of Equity
7th Jun 201812:09 pmRNSResult of AGM
7th Jun 20187:00 amRNSAGM Statement
31st May 20182:56 pmRNSIssue of Equity
17th May 20188:01 amRNSResult of Secondary Placing
16th May 20183:05 pmRNSProposed Secondary Placing
15th May 20187:00 amRNSIssue of Equity
27th Apr 20183:59 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAccolade Release 12.0
23rd Mar 20183:56 pmRNSIssue of Equity
23rd Mar 20187:00 amRNSIssue of Equity
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSSopheon named in Annual Reader's Choice List
12th Feb 20189:24 amRNSGrant of Options / PDMR dealing
5th Feb 20183:35 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.